X0306 4 2013-02-08 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001202294 SIGAL ELLIOT BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 1 EVP, CSO & President R&D Common Stock, $0.10 par value 2013-02-08 4 M 0 147749.0000 17.5100 A 195801.0000 D Common Stock, $0.10 par value 2013-02-08 4 M 0 70000.0000 22.7300 A 265801.0000 D Common Stock, $0.10 par value 2013-02-08 4 M 0 48333.0000 28.1100 A 314134.0000 D Common Stock, $0.10 par value 2013-02-08 4 S 0 224705.0000 36.7900 D 89429.0000 D Common Stock, $0.10 par value 1616.0100 I By BMY Savings & Investment Program Common Stock, $0.10 par value 37412.0000 I By C. Elliott Sigal 2012 Irrevocable Trust Common Stock, $0.10 par value 37412.0000 I By Ruth L. Sigal Irrevocable Trust Common Stock, $0.10 par value 18707.0000 I By Sigal Family Investments, LLC Executive Option (right to buy) 17.5100 2013-02-08 4 M 0 147749.0000 0.0000 D 2019-03-02 Common Stock, $0.10 par value 147749.0000 0.0000 D Executive Option (right to buy) 22.7300 2013-02-08 4 M 0 70000.0000 0.0000 D 2016-03-06 Common Stock, $0.10 par value 70000.0000 25795.0000 D Option (right to buy) 28.1100 2013-02-08 4 M 0 48333.0000 0.0000 D 2014-03-01 Common Stock, $0.10 par value 48333.0000 0.0000 D The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.73 to $36.93, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Based on a plan statement as of the end of the most recent fiscal quarter. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 3, 2009. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 7, 2006. Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 2, 2004. /s/ Robert J. Wollin, attorney-in-fact for Elliott Sigal, M.D., Ph.D 2013-02-11